Advent Shines at ASIA Labex 2025, Chandigarh: A Showcase of Innovation and Quality

Advent Shines at ASIA Labex 2025, Chandigarh: A Showcase of Innovation and Quality

27 Mar 2025


Chandigarh, March 2025 – Advent, a leading provider of high-quality chemicals and solutions, is excited to announce its participation at ASIA Labex 2025 in Chandigarh, held at the Parade Ground, Sector 17, from March 20-22, 2025. The Advent exhibit is located at Stall No. B56, which would host various industry experts and academic researchers because of its commitment to promote innovation and partnership connections.

At the event, Advent showcased its premium offerings in key categories, including:

  • Pharmacopoeial Solvents: High-quality, compliant, pure, FDA-approved, and cGMP-certified, ensuring the highest standards for pharmaceutical manufacturing.

  • Fmoc Amino Acids: Pure and analytical, ideal for peptide synthesis and research applications.

Business Development Manager Pankaj Pagare at Advent expressed satisfaction with the visitation surge from attendees at the event. “The event granted us access to extraordinary connections with industry leaders and researchers to build potential collaborations while displaying our dedication to advancing pharmaceutical research and manufacturing.

Advent’s ASIA Labex 2025 participation proved incredibly beneficial by allowing the company to both involve itself with scientists and study emerging trends while building strategic alliances for future business expansion.

For more information about Advent's products and solutions, visit www.adventchembio.com.

About Advent

Advent Chembio Pvt. Ltd. is a leading innovator in the Chemical and Life Sciences industry. We specialize in delivering customized intermediates, fine and specialty chemicals, and performance materials tailored to meet the unique needs of our clients. Our vision is to be a globally recognized player, known for our commitment to quality, innovation, and customer-centric solutions. By fostering collaborative partnerships, we strive to create value and achieve mutually beneficial outcomes for all stakeholders.








Share this on